SLC19A1 and cancer: SLC19A1 dysfunction has been associated with fetal abnormalities, megaloblastic anemia, neurologic disorders, cardiovascular disease, and cancer (Yang et al., 2003; Matherly and Hou, 2008; Svaton et al., 2020).